RxDoctor Payments Data

Michael Retino, DO

Orthopaedic Surgery · Bradenton, FLNPI 1154390532

Payments from drug & device makers

$5,480in general payments, 2019–2025

Across 61 payments — averaging $89.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$3K
  • Arthrex$1K
  • MVP Orthopedics Inc$559
  • Coastal Medical Technologies LLC$190
  • Johnson & Johnson$121
  • Biocomposites Inc$80
  • plus $178 from 4 others

What the payments were for

  • Travel & lodging$1964%
  • Food & beverage$3,78769%
  • Education$1,49727%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Stryker35$2,956
Arthrex2$1,396
MVP Orthopedics Inc12$559
Coastal Medical Technologies LLC4$190
Johnson & Johnson2$121
Biocomposites Inc1$80
Smith+Nephew1$60
Innovation Technologies Inc1$45
KCI USA, Inc.1$40
Vivus LLC2$33

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,480 in reported general payments places this provider in the 45th percentile of 1,263 orthopaedic surgery providers in Florida.

See all orthopaedic surgery providers in Florida

Medicare billing

Part B allowed, 2024
$20,385
Medicare patients
35
Services billed
128

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen33$268
Meloxicam49$118
Cefadroxil15$118

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Bradenton

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →